NOS3 and hypertensive disorder: Reducing renal monocyte/macrophage-driven inflammation and oxidative stress restores eNOS/NO activity and attenuates HTN and renal injury (glomerulosclerosis, proteinuria, fibrosis) in Ang II-induced HTN [41].